$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

$ssy Overview Financials Valuation SEC Filings Company Website

2015 Form 10-K Financial Statement

#000119312515328941 Filed on September 25, 2015

Income Statement

Concept	2015	2014 Q2	2014 Q1
Revenue	$73.75M	$21.60M	$30.24M
YoY Change	-36.7%	-15.11%	-5.64%
Cost Of Revenue	$3.616M	$4.270M	$1.289M
YoY Change	9.98%	-0.23%	-27.46%
Gross Profit	$70.13M	-$880.0K	$28.95M
YoY Change	-38.05%	-104.14%	-4.36%
Gross Profit Margin	95.1%	-4.07%	95.74%
Selling, General & Admin	$42.78M	-$1.400M	$14.13M
YoY Change	3.27%	-108.01%	-20.88%
% of Gross Profit	61.01%		48.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.681M	$3.660M	$773.0K
YoY Change	-26.79%	-9.63%	-24.36%
% of Gross Profit	3.82%		2.67%
Operating Expenses	$51.48M	-$2.430M	$17.85M
YoY Change	1.71%	-113.06%	-19.56%
Operating Profit	$2.220M	$1.550M	-$465.0K
YoY Change	113.05%	-41.29%	73.51%
Interest Expense	$861.0K	-$230.0K	$234.0K
YoY Change	-8.79%	-20.69%	-22.0%
% of Operating Profit	38.78%	-14.84%
Other Income/Expense, Net		-$1.040M	-$43.00K
YoY Change		-1255.56%	-146.24%
Pretax Income	$1.380M	$1.260M	-$681.0K
YoY Change	-205.91%	-46.38%	19.89%
Income Tax	$893.0K	$740.0K	-$105.0K
% Of Pretax Income	64.71%	58.73%
Net Earnings	$245.0K	$1.350M	-$964.0K
YoY Change	-144.95%	-37.59%	418.28%
Net Earnings / Revenue	0.33%	6.25%	-3.19%
Basic Earnings Per Share	$0.03	$0.14	-$0.10
Diluted Earnings Per Share	$0.03	$0.14	-$0.10
COMMON SHARES
Basic Shares Outstanding	9.443M shares	9.443M shares	9.446M shares
Diluted Shares Outstanding	9.496M shares	9.476M shares	9.443M shares

Balance Sheet

Concept	2015	2014 Q2	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.974M	$3.600M	$3.800M
YoY Change	66.55%	33.33%	18.75%
Cash & Equivalents	$5.974M	$3.587M	$3.823M
Short-Term Investments
Other Short-Term Assets	$8.291M	$8.500M	$8.700M
YoY Change	-3.38%	13.33%	-13.86%
Inventory	$3.148M	$3.757M	$4.005M
Prepaid Expenses
Receivables	$7.679M	$2.786M	$1.195M
Other Receivables	$0.00	$0.00	$300.0K
Total Short-Term Assets	$25.09M	$25.78M	$28.05M
YoY Change	-2.65%	-8.25%	-12.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.24M	$23.33M	$29.27M
YoY Change	-38.28%	-23.71%	-3.96%
Goodwill		$461.0K	$461.0K
YoY Change		0.0%	0.0%
Intangibles		$2.979M	$3.067M
YoY Change		-6.17%	-4.51%
Long-Term Investments
YoY Change
Other Assets	$14.50M	$1.025M	$1.478M
YoY Change	25.44%	-35.41%	-14.12%
Total Long-Term Assets	$32.04M	$38.07M	$38.58M
YoY Change	-15.85%	-4.61%	-3.35%
TOTAL ASSETS
Total Short-Term Assets	$25.09M	$25.78M	$28.05M
Total Long-Term Assets	$32.04M	$38.07M	$38.58M
Total Assets	$57.13M	$63.85M	$66.63M
YoY Change	-10.52%	-6.11%	-7.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.688M	$4.530M	$5.174M
YoY Change	-40.66%	-17.25%	-19.27%
Accrued Expenses	$4.853M	$6.500M	$5.900M
YoY Change	-25.34%	18.18%	-9.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$816.0K	$561.0K	$9.198M
YoY Change	45.45%	-94.12%	895.45%
Total Short-Term Liabilities	$10.76M	$16.51M	$23.94M
YoY Change	-34.79%	-25.8%	21.61%
LONG-TERM LIABILITIES
Long-Term Debt	$11.23M	$11.95M	$8.453M
YoY Change	-6.02%	36.89%	-52.21%
Other Long-Term Liabilities	$1.575M	$807.0K	$847.0K
YoY Change	-24.1%	-2.18%	6.41%
Total Long-Term Liabilities	$12.80M	$14.02M	$10.80M
YoY Change	-8.69%	16.72%	-47.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.76M	$16.51M	$23.94M
Total Long-Term Liabilities	$12.80M	$14.02M	$10.80M
Total Liabilities	$23.57M	$30.53M	$34.74M
YoY Change	-22.8%	-10.89%	-13.98%
SHAREHOLDERS EQUITY
Retained Earnings		$15.49M	$14.14M
YoY Change		-3.4%	1.93%
Common Stock		$18.17M	$4.722M
YoY Change		284.71%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.56M	$33.30M	$31.89M
YoY Change
Total Liabilities & Shareholders Equity	$57.13M	$63.85M	$66.63M
YoY Change	-10.52%	-6.11%	-7.28%

Cashflow Statement

Concept	2015	2014 Q2	2014 Q1
OPERATING ACTIVITIES
Net Income	$245.0K	$1.350M	-$964.0K
YoY Change	-144.95%	-37.59%	418.28%
Depreciation, Depletion And Amortization	$2.681M	$3.660M	$773.0K
YoY Change	-26.79%	-9.63%	-24.36%
Cash From Operating Activities	$2.938M	$570.0K	-$230.0K
YoY Change	-24.51%	-75.54%	-94.85%
INVESTING ACTIVITIES
Capital Expenditures	$1.235M	-$510.0K	$336.0K
YoY Change	-16.72%	-81.91%	-67.35%
Acquisitions
YoY Change
Other Investing Activities	$6.124M	$0.00	$80.00K
YoY Change	-3927.5%	-100.0%	-27.27%
Cash From Investing Activities	$4.811M	-$510.0K	-$360.0K
YoY Change	-355.5%	-74.75%	-60.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net	$695.0K
YoY Change	-12.58%
Cash From Financing Activities	-5.362M	-300.0K	-150.0K
YoY Change	483.46%	-18.92%	-171.43%
NET CHANGE
Cash From Operating Activities	2.938M	570.0K	-230.0K
Cash From Investing Activities	4.811M	-510.0K	-360.0K
Cash From Financing Activities	-5.362M	-300.0K	-150.0K
Net Change In Cash	2.387M	-240.0K	-740.0K
YoY Change	118.99%	300.0%	-85.69%
FREE CASH FLOW
Cash From Operating Activities	$2.938M	$570.0K	-$230.0K
Capital Expenditures	$1.235M	-$510.0K	$336.0K
Free Cash Flow	$1.703M	$1.080M	-$566.0K
YoY Change	-29.31%	-79.03%	-89.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	ssy	Minimum Outstanding Stock Percentage Required To Trigger Poison Pill MinimumOutstandingStockPercentageRequiredToTriggerPoisonPill	0.20	pure
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9443408	shares
CY2014Q4	dei	Entity Public Float EntityPublicFloat	7129321
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400499	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.62
CY2012Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29291000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-497000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2057000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-497000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	617499	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	404163	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.18
CY2013Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1353000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7761000
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33743000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-406000
CY2013Q2	us-gaap	Assets Assets	68003000
CY2013Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	737000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2497000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-406000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548999	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.71
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	448998	shares
CY2014Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2014Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.97
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14023000
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	13444000
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4186000
CY2014Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11948000
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	807000
CY2014Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	73000
CY2014Q2	us-gaap	Long Term Debt LongTermDebt	12509000
CY2014Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2314000
CY2014Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	561000
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4530000
CY2014Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1366000
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6903000
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15486000
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63847000
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33318000
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30389000
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16506000
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2577000
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2014Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	4842000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-334000
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10000
CY2014Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4288000
CY2014Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	28568000
CY2014Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	9850000
CY2014Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	341000
CY2014Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9987000
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1025000
CY2014Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	14746000
CY2014Q2	us-gaap	Assets Assets	63847000
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2979000
CY2014Q2	us-gaap	Inventory Net InventoryNet	3757000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	467000
CY2014Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2786000
CY2014Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	535000
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23326000
CY2014Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-549000
CY2014Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7410000
CY2014Q2	us-gaap	Assets Current AssetsCurrent	25775000
CY2014Q2	us-gaap	Land Land	1811000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2341000
CY2014Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23336000
CY2014Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	816000
CY2014Q2	us-gaap	Goodwill Goodwill	461000
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2476000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3587000
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4432000
CY2014Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-549000
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	53715000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2978000
CY2014Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	5849000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	218000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-334000
CY2014Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	16753000
CY2014Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3223000
CY2014Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	-14000
CY2014Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	-14000
CY2014Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1549000
CY2014Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	2099000
CY2014Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	1268000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	590142	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	142000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.46
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	470142	shares
CY2015Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2015Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.73
CY2015Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.50
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	392000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	816000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	907000
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12804000
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	13481000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	821000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1917000
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3946000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	152000
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11229000
CY2015Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	137000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1851000
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	681000
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	64000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	620000
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	12045000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	7280000
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1479000
CY2015Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	816000
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4459000
CY2015Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1476000
CY2015Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	88000
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5347000
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15731000
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57128000
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2015Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	64000
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33560000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	657000
CY2015Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	70000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	159000
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32259000
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.15
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	30000
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10764000
CY2015Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	65000
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2564000
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2015Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-374000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	277000
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	12045000
CY2015Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	67000
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	67000
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4096000
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	33000
CY2015Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	29294000
CY2015Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	9625000
CY2015Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9416000
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1520000
CY2015Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	9703000
CY2015Q2	us-gaap	Assets Assets	57128000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	142000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	142000
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2837000
CY2015Q2	us-gaap	Inventory Net InventoryNet	3758000
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	281000
CY2015Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1126000
CY2015Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	600000
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22333000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	142000
CY2015Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-628000
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6852000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	144000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	125000
CY2015Q2	us-gaap	Assets Current AssetsCurrent	25092000
CY2015Q2	us-gaap	Land Land	1811000
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1365000
CY2015Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23487000
CY2015Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	848000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	837000
CY2015Q2	us-gaap	Goodwill Goodwill	461000
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2642000
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5974000
CY2015Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4885000
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9445000	shares
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	260000	shares
CY2015Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Five LongTermDebtContractualCommitmentsForInterestInYearFive	452000
CY2015Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	556000
CY2015Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	894000
CY2015Q2	ssy	Common Stock Shares Issued And Outstanding CommonStockSharesIssuedAndOutstanding	9443334	shares
CY2015Q2	ssy	Plans Assets Invested In Cash And Short Term Investments PlansAssetsInvestedInCashAndShortTermInvestments	0.59	pure
CY2015Q1	us-gaap	Malpractice Insurance Description MalpracticeInsuranceDescription	Claim made under its insurance policy covering, among other things, employee theft relating to misappropriation of funds by two now former employees over an eight year period beginning in 2006.
CY2015Q1	us-gaap	Insurance Recoveries InsuranceRecoveries	1000000
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2015Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-628000
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	54592000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2015Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1967000
CY2015Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	238000
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-374000
CY2015Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	14972000
CY2015Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2627000
CY2015Q2	ssy	Plan Expected To Pay In Pension Benefits Through Three Years PlanExpectedToPayInPensionBenefitsThroughThreeYears	437000
CY2015Q2	ssy	Plans Assets Invested In Equity Investments PlansAssetsInvestedInEquityInvestments	0.25	pure
CY2015Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Two LongTermDebtContractualCommitmentsForInterestInYearTwo	681000
CY2015Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year After Five Year LongTermDebtContractualCommitmentsForInterestInYearAfterFiveYear	2075000
CY2015Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	-28000
CY2015Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	-28000
CY2015Q2	ssy	Long Term Debt Contractual Commitments For Interest In Next Twelve Months LongTermDebtContractualCommitmentsForInterestInNextTwelveMonths	695000
CY2015Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1365000
CY2015Q2	ssy	Long Term Debt Contractual Commitments LongTermDebtContractualCommitments	4970000
CY2015Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Three LongTermDebtContractualCommitmentsForInterestInYearThree	577000
CY2015Q2	ssy	Plans Assets Invested In Fixed Income Investments PlansAssetsInvestedInFixedIncomeInvestments	0.15	pure
CY2015Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Four LongTermDebtContractualCommitmentsForInterestInYearFour	490000
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.67
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	43000	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	617000	shares
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.13
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.20
CY2013	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.80	pure
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.67
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.22
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2016000
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9445000	shares
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.20
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4579000
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-873000
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2116000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3389000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1521000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	86000
CY2013	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-558000
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	54000
CY2013	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-5931000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	440000
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1532000
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4791000
CY2013	us-gaap	Insurance Recoveries InsuranceRecoveries	0
CY2013	us-gaap	Net Income Loss NetIncomeLoss	4488000
CY2013	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1868000
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	95119000
CY2013	us-gaap	Interest Paid InterestPaid	1752000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	144000
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	213000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-1856000
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-44000
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	6356000
CY2013	us-gaap	Health Care Organization Significant Changes In Estimates HealthCareOrganizationSignificantChangesInEstimates	-356000
CY2013	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	10450000
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	91000
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	761000
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	17413000
CY2013	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	7984000
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-160000
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	106000
CY2013	us-gaap	Interest Expense InterestExpense	1533000
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	91000
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	4855000
CY2013	us-gaap	Cost Of Services CostOfServices	5920000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10964000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2781000
CY2013	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	789000
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3794000
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	12075000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	86000
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2013	us-gaap	Supplies Expense SuppliesExpense	8105000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	29000
CY2013	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	9637000
CY2013	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	2357000
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1571000
CY2013	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1496000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-4302000
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1152000
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	45327000
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22363000
CY2013	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	213000
CY2013	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3486000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13420000
CY2013	us-gaap	Depreciation Depreciation	3341
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4048000
CY2013	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	12716000
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	514000
CY2013	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-1032000
CY2013	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	91000
CY2013	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	55000
CY2013	ssy	Incentive Payments Received IncentivePaymentsReceived	4368000
CY2013	ssy	Disposal Group Including Discontinued Operation Revenue Net Of Expenses DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses	22937000
CY2013	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	4791000
CY2013	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.22
CY2013	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	229000
CY2013	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	-1135000
CY2013	ssy	Expenses On Physician Guarantees And Recruitment ExpensesOnPhysicianGuaranteesAndRecruitment	96000
CY2013	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	3777000
CY2013	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	2944000
CY2013	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	106000
CY2013	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	104756000
CY2013	ssy	Proceeds From Issuance Of Longterm Debt Discontinued Operations ProceedsFromIssuanceOfLongtermDebtDiscontinuedOperations	624000
CY2013	ssy	Other Expense Continuing And Discontinued Operations OtherExpenseContinuingAndDiscontinuedOperations	6725000
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.02
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	89500	shares
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.04
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.93	pure
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.02
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.71
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.71
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13000	shares
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3892000
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9456000	shares
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.04
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1590000
CY2014	us-gaap	Insurance Recoveries InsuranceRecoveries	0
CY2014	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	0
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-545000
CY2014	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-333000
CY2014	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-41000
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	91974000
CY2014	us-gaap	Interest Paid InterestPaid	1128000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1460000
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	1304000
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	222000
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-212000
CY2014	us-gaap	Health Care Organization Significant Changes In Estimates HealthCareOrganizationSignificantChangesInEstimates	325000
CY2014	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	72000
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-325000
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-41000
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	796000
CY2014	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	7365000
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	160000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-473000
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2505000
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1881000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	319000
CY2014	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	59000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	652000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	48000
CY2014	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	44000
CY2014	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	8000
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	93000
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1382000
CY2014	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1090000
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	427000
CY2014	us-gaap	Interest Expense InterestExpense	944000
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	72000
CY2014	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-113000
CY2014	us-gaap	Cost Of Services CostOfServices	5095000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-919000
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	12178000
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-283000
CY2014	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2014	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	108000
CY2014	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	46000
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1130000
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48000
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2014	us-gaap	Supplies Expense SuppliesExpense	7608000
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	16000
CY2014	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	8254000
CY2014	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	555000
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1842000
CY2014	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-99000
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	935000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	108000
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	42831000
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22110000
CY2014	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3119000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1883000
CY2014	us-gaap	Depreciation Depreciation	2966
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3662000
CY2014	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	17000
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	11686000
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	255000
CY2014	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	3342000
CY2014	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	535000
CY2014	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	72000
CY2014	ssy	Incentive Payments Received IncentivePaymentsReceived	2532000
CY2014	ssy	Disposal Group Including Discontinued Operation Revenue Net Of Expenses DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses	13999000
CY2014	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1590000
CY2014	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	0.71
CY2014	ssy	Net Operating Loss Carryforward Expiration Year NetOperatingLossCarryforwardExpirationYear	2023
CY2014	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	133000
CY2014	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	1135000
CY2014	ssy	Expenses On Physician Guarantees And Recruitment ExpensesOnPhysicianGuaranteesAndRecruitment	82000
CY2014	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	3416000
CY2014	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	803000
CY2014	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	123000
CY2014	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	100228000
CY2014	ssy	Proceeds From Issuance Of Longterm Debt Discontinued Operations ProceedsFromIssuanceOfLongtermDebtDiscontinuedOperations	0
CY2014	ssy	Other Expense Continuing And Discontinued Operations OtherExpenseContinuingAndDiscontinuedOperations	3087000
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><b>1.</b></td> <td valign="top" align="left"><b>BUSINESS OPERATIONS</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> SunLink Health Systems, Inc. through subsidiaries (“SunLink”, “we”, “our”, “ours”, “us” or the “Company”), owns businesses which are providers of healthcare services in certain markets in the United States. SunLink’s business is composed of the ownership of two business segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">The Healthcare Facilities Segments, which is composed of three operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"> </td> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Three community hospital subsidiaries in two states with a total of 183 licensed beds;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"> </td> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Two nursing homes with a total of 166 licensed beds, each of which is located adjacent to a corresponding SunLink community hospital; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"> </td> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">A healthcare facility which is currently vacant except for two offices rented to a physician and a testing lab.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">The Specialty Pharmacy Segment, which is composed of four operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"> </td> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Retail pharmacy products and services, all of which are conducted in rural markets;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"> </td> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Institutional pharmacy services;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"> </td> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Specialty pharmacy services; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"> </td> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Durable medical equipment.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy operations since 2008. Our Specialty Pharmacy Segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of our SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</p> </div>
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0203	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	48857	shares
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.05
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000096793
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y9M22D
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.50
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.05
CY2015	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.07
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> <b><i>Concentrations of Credit Risk</i></b>—SunLink’s Healthcare Facilities segment subsidiaries grant unsecured credit to their patients, most of who reside in the service area of the subsidiaries’ facilities and are insured under third-party agreements. Medicare and Medicaid patient accounts represent SunLink’s only significant concentrations of credit risk. For SunLink’s Healthcare Facilities Segment, Medicare net revenues were approximately 41%, 40%, and 39% of net revenues for the years ended June 30, 2015, 2014 and 2013, respectively. For SunLink’s Healthcare Facilities Segment, Medicaid was approximately 22%, 22%, and 21% of net revenues for the years ended June 30, 2015, 2014 and 2013, respectively. For SunLink’s Healthcare Facilities Segment, Medicare receivables were approximately 45% and 47% of receivables—net at June 30, 2015 and 2014, respectively, while Medicaid receivables were approximately 15% and 12% of receivables—net at June 30, 2015 and 2014, respectively.</p> </div>
CY2015	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.84	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.49
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.49
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	53000	shares
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2938000
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2015	dei	Entity Registrant Name EntityRegistrantName	SUNLINK HEALTH SYSTEMS INC
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9496000	shares
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2015	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	Estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis
CY2015	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2631	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	90000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1335000
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0
CY2015	us-gaap	Interest Expense InterestExpense	861000
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> <b><i>Management Estimates</i></b>—The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates made by management involve reserves for adjustments to net patient service revenues, evaluation of the recoverability of assets, including accounts receivable and intangible assets, and the assessment of litigation and contingencies, including income taxes and related tax asset valuation allowances, all as discussed in more detail in the remainder of these notes to the consolidated financial statements. Actual results could differ materially from these estimates.</p> </div>
CY2015	dei	Trading Symbol TradingSymbol	SSY
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.07
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2015	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	Depreciation is recognized over the estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2387000
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	216000
CY2015	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1302000
CY2015	us-gaap	Insurance Recoveries InsuranceRecoveries	1000000
CY2015	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	117000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	245000
CY2015	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	674000
CY2015	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	21000
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	91833000
CY2015	us-gaap	Interest Paid InterestPaid	914000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	292000
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	2534000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1000
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-429000
CY2015	us-gaap	Health Care Organization Significant Changes In Estimates HealthCareOrganizationSignificantChangesInEstimates	-262000
CY2015	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-197000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-40000
CY2015	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-533000
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	21000
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	695000
CY2015	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	3599000
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	205000
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-225000
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	57000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1694000
CY2015	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	60000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1020000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	37000
CY2015	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	129000
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	87000
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	21042000
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2479000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4811000
CY2015	us-gaap	Depreciation Depreciation	2274
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2681000
CY2015	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-13000
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9345000
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-40000
CY2015	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-301000
CY2015	us-gaap	Cost Of Services CostOfServices	5229000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5362000
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	11989000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1517000
CY2015	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000
CY2015	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	112000
CY2015	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	67000
CY2015	us-gaap	Defined Benefit Plans Estimated Future Employer Contributions In Next Fiscal Year DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear	128000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1686000
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	175000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37000
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	56000
CY2015	us-gaap	Supplies Expense SuppliesExpense	7429000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	12000
CY2015	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	8321000
CY2015	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	703000
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9000
CY2015	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-655000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-497000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	576000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	43127000
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	363000
CY2015	ssy	Defined Contribution Plan Employer Matching Contribution DefinedContributionPlanEmployerMatchingContribution	120000
CY2015	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-1660000
CY2015	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	600000
CY2015	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	-40000
CY2015	ssy	Age Of Participants To Take Monthly Pension Benefits One AgeOfParticipantsToTakeMonthlyPensionBenefitsOne	P65Y
CY2015	ssy	Number Of Stockholders To Whom Shares Issued NumberOfStockholdersToWhomSharesIssued	68	Stockholders
CY2015	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	25000
CY2015	ssy	Maximum Number Of Shares Held By Stockholders Under Tender Offer MaximumNumberOfSharesHeldByStockholdersUnderTenderOffer	99	shares
CY2015	ssy	Incentive Payments Received IncentivePaymentsReceived	50000
CY2015	ssy	Disposal Group Including Discontinued Operation Revenue Net Of Expenses DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses	6988000
CY2015	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1302000
CY2015	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.49
CY2015	ssy	Number Of Physicians Under Guarantee Agreements NumberOfPhysiciansUnderGuaranteeAgreements	1	Physician
CY2015	ssy	Maximum Period Of Accounts Receivable Written Off MaximumPeriodOfAccountsReceivableWrittenOff	P120D
CY2015	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	11000
CY2015	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	0
CY2015	ssy	Expenses On Physician Guarantees And Recruitment ExpensesOnPhysicianGuaranteesAndRecruitment	67000
CY2015	ssy	Period Of Physician Guarantee Agreement PeriodOfPhysicianGuaranteeAgreement	P3Y
CY2015	ssy	Expected Return On Investment ExpectedReturnOnInvestment	0.04	pure
CY2015	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	50000
CY2015	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	557000
CY2015	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	4842000
CY2015	ssy	Number Of Stockholders NumberOfStockholders	480	Stockholders
CY2015	ssy	Stock Issued During Period Value Bonus Shares StockIssuedDuringPeriodValueBonusShares	100000
CY2015	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	100154000
CY2015	ssy	Proceeds From Issuance Of Longterm Debt Discontinued Operations ProceedsFromIssuanceOfLongtermDebtDiscontinuedOperations	0
CY2015	ssy	Other Expense Continuing And Discontinued Operations OtherExpenseContinuingAndDiscontinuedOperations	753000
CY2012	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.06
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-964000
CY2014Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-576000
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	24466000
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-411000
CY2015Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-316000
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	23351000
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.07
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9476000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.07
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	1350000
CY2014Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	673000
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	21599000
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9490000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	92000
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	22980000
CY2015Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	112000
CY2014Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-111000
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	22376000
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2014Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.10
CY2014Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9497000	shares
CY2014Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.10
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	977000
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-1158000
CY2013Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-780000
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	22029000
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
CY2013Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9478000	shares
CY2013Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	227000
CY2013Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	350000
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	23880000
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.01
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-413000
CY2014Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	989000
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	23126000

Files In Submission

Name	View Source	Status
0001193125-15-328941-index-headers.html	Edgar Link	pending
0001193125-15-328941-index.html	Edgar Link	pending
0001193125-15-328941.txt	Edgar Link	pending
0001193125-15-328941-xbrl.zip	Edgar Link	pending
d93040d10k.htm	Edgar Link	pending
d93040dex1021.htm	Edgar Link	pending
d93040dex211.htm	Edgar Link	pending
d93040dex231.htm	Edgar Link	pending
d93040dex311.htm	Edgar Link	pending
d93040dex312.htm	Edgar Link	pending
d93040dex321.htm	Edgar Link	pending
d93040dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g93040g18o27.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssy-20150630.xml	Edgar Link	completed
ssy-20150630.xsd	Edgar Link	pending
ssy-20150630_cal.xml	Edgar Link	unprocessable
ssy-20150630_def.xml	Edgar Link	unprocessable
ssy-20150630_lab.xml	Edgar Link	unprocessable
ssy-20150630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

2015 Form 10-K Financial Statement

#000119312515328941 Filed on September 25, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY SUNLINK HEALTH SYSTEMS INC Stock $ssy

2015 Form 10-K Financial Statement

#000119312515328941 Filed on September 25, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy